Menu
Recombinant insulin enhances CHO-K1 fed-batch culture performance and consistency while reducing costs in cell culture processes.
Scale-up production, optimise processes, and increase cellular products yields with our Recombinant Insulin that’s approved by regulatory bodies worldwide.
Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Novo Nordisk Pharmatech is a leading Benzalkonium Chloride manufacturer. We provide only the best and safest ingredients.
Scale-up production, optimise processes, and increase cellular products yields with our Recombinant Insulin that’s approved by regulatory bodies worldwide.
“Excellent service”“Skilled people and clear communication”“Stable product quality”“Fast response and meeting delivery times”“Customer support is absolutely TOP quality” These are some of the comments in our latest customer satisfaction surveys, and we are ecstatic about the results 👏 Our customers’ satisfaction and loyalty are not goals – they´re necessary for
Request insights Select the documents you’re interested in, and we’ll email them to you. Name * Email * Insulin case studies Enhancing protein productivity in CHO-K1 using Recombinant Insulin in cell culture media Boosting protein productivity in CHO-S cells through cell culture media optimization Boosting influenza virus production in HEK293
Enhance efficiency and safety in upstream biomanufacturing processes On Tuesday, May 20, between 11 AM and 1:30 PM, all employees at AstraZeneca Gaithersburg are invited to the vendor show with Novo Nordisk Pharmatech in the main lobby – JBB main atrium. You can come by to get valuable insights on
Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]
CVR-no. 13246149
